Vittorio Coiro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Vittorio Coiro has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
P. Chiodera
Department of Internal Medicine and Biomedical Sciences, University of Parma, Parma, Italy
19 shared publicationsPaolo Chiodera
University of Parma, Graduate School in Physical Exercise and Sport Sciences
17 shared publications- Riccardo Volpi
Department of Internal Medicine, School of Medicine, University of Parma, Parma, Italy
16 shared publications Riccardo Volpi
9 shared publicationsAndrea Melani
Graduate School in Physical Exercise and Sport Sciences, University of Parma, Parma, Italy
6 shared publicationsElio Volta
Graduate School in Physical Exercise and Sport Sciences, University of Parma, Parma, Italy
6 shared publications
Latest Publications
- Open Access
- 29 December 2011
- Published by Springer Nature in Nature Precedings
- p. 1
NPY Levels In Type 1 Diabetic Men of Different Duration.
Background: The aim of the present study was to evaluate whether the different duration of type 1 diabetes mellitus influences basal NPY secretion. Design: The NPY concentrations were measured in sixty-eight men with insulin-dependent diabetes mellitus (IDDM) (duration: group 1 (n.21) 5 years and 10 years (range: 11-14 years)) and in age matched normal control subjects (n. 30). Results: The NPY levels were significantly lower in group 3 than in group 2 and 1 and in the control group, in group 2 than in group 1 and in the control group and in group 1 than control group. Conclusion: These results support the view that the duration of diabetes may have a modulatory role in the decreased basal NPY secretion observed in diabetics.
- 29 December 2011
- Published by Springer Nature in Nature Precedings
- p. 1
Open AccessNPY Levels In Type 1 Diabetic Men of Different Duration.
Background: The aim of the present study was to evaluate whether the different duration of type 1 diabetes mellitus influences basal NPY secretion. Design: The NPY concentrations were measured in sixty-eight men with insulin-dependent diabetes mellitus (IDDM) (duration: group 1 (n.21) 5 years and 10 years (range: 11-14 years)) and in age matched normal control subjects (n. 30). Results: The NPY levels were significantly lower in group 3 than in group 2 and 1 and in the control group, in group 2 than in group 1 and in the control group and in group 1 than control group. Conclusion: These results support the view that the duration of diabetes may have a modulatory role in the decreased basal NPY secretion observed in diabetics.
- 1 December 2011
- Published by Elsevier in Regulatory Peptides
- Vol. 172 (1-3) , 41-43
Glucoreceptors located in the brain mediate NPY release induced by hypoglycemia in normal men
- 1 December 2011
- Published by Elsevier in Regulatory Peptides
- Vol. 172 (1-3) , 41-43
Glucoreceptors located in the brain mediate NPY release induced by hypoglycemia in normal men
- 10 October 2011
- Published by Elsevier in Regulatory Peptides
- Vol. 170 (1-3) , 62-64
Inhibitory effect of somatostatin on the NPY response to insulin-induced hypoglycemia and the role of endogenous opioids
- 10 October 2011
- Published by Elsevier in Regulatory Peptides
- Vol. 170 (1-3) , 62-64
Inhibitory effect of somatostatin on the NPY response to insulin-induced hypoglycemia and the role of endogenous opioids
- 1 April 2011
- Published by Elsevier in Regulatory Peptides
- Vol. 167 (2-3) , 167-169
Increased arginine-vasopressin response to hypertonic stimulation and upright posture in idiopathic hyperprolactinemia
- 1 April 2011
- Published by Elsevier in Regulatory Peptides
- Vol. 167 (2-3) , 167-169
Increased arginine-vasopressin response to hypertonic stimulation and upright posture in idiopathic hyperprolactinemia
- 1 April 2011
- Published by Elsevier in Neuropeptides
- Vol. 45 (2) , 139-142
Oxytocin does not modify GH, ACTH, cortisol and prolactin responses to Ghrelin in normal men
- 1 April 2011
- Published by Elsevier in Neuropeptides
- Vol. 45 (2) , 139-142
Oxytocin does not modify GH, ACTH, cortisol and prolactin responses to Ghrelin in normal men
- 1 March 2011
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 59 (3) , 599-601
Inhibitory Effect of Dexamethasone on Arginine-Vasopressin Release Induced by Physical Exercise in Man
To establish whether glucocorticoids inhibit the arginine-vasopressin (AVP) response to physical exercise, 10 healthy men underwent bicycle ergometer tests until exhaustion (exercise control test, exercise plus dexamethasone [2 or 4 mg in an intravenous bolus]). Physiological and biochemical variables were similar in all tests. Pretreatment with dexamethasone (2 or 4 mg) partially but significantly decreased the AVP response induced by physical exercise. Our results demonstrate a partial inhibition induced by glucocorticoids of AVP neurosecretion during cycle ergometer tests.
- 1 March 2011
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 59 (3) , 599-601
Inhibitory Effect of Dexamethasone on Arginine-Vasopressin Release Induced by Physical Exercise in Man
To establish whether glucocorticoids inhibit the arginine-vasopressin (AVP) response to physical exercise, 10 healthy men underwent bicycle ergometer tests until exhaustion (exercise control test, exercise plus dexamethasone [2 or 4 mg in an intravenous bolus]). Physiological and biochemical variables were similar in all tests. Pretreatment with dexamethasone (2 or 4 mg) partially but significantly decreased the AVP response induced by physical exercise. Our results demonstrate a partial inhibition induced by glucocorticoids of AVP neurosecretion during cycle ergometer tests.
- 1 March 2011
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 118 (8) , 1173-1175
Naloxone decreases the inhibitory effect of somatostatin on GH release induced by cigarette smoking in man
To establish whether somatostatin (SRIH) exerts its inhibitory effect on the nicotine-induced release of GH by interacting with an opioid pathway, normal volunteers were treated with naloxone during (2 no-filter) cigarettes smoking and with SRIH. Nicotine significantly increased serum GH levels about 3.5 fold. Naloxone alone did not change GH rise induced by cigarette smoking. The stimulatory effect of GH by nicotine was completely blocked by SRIH. In the presence of both SRIH and naloxone, GH levels rose 1.5 fold in response to nicotine. Since naloxone only partially reversed the inhibiting action of SRIH, only a partial involvement of opioid peptides in SRIH action might be supposed. Alternatively, SRIH and naloxone-sensitive opiates might produce this inhibiting effect on GH rise in response to cigarette smoking through independent pathways.
- 1 March 2011
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 118 (8) , 1173-1175
Naloxone decreases the inhibitory effect of somatostatin on GH release induced by cigarette smoking in man
To establish whether somatostatin (SRIH) exerts its inhibitory effect on the nicotine-induced release of GH by interacting with an opioid pathway, normal volunteers were treated with naloxone during (2 no-filter) cigarettes smoking and with SRIH. Nicotine significantly increased serum GH levels about 3.5 fold. Naloxone alone did not change GH rise induced by cigarette smoking. The stimulatory effect of GH by nicotine was completely blocked by SRIH. In the presence of both SRIH and naloxone, GH levels rose 1.5 fold in response to nicotine. Since naloxone only partially reversed the inhibiting action of SRIH, only a partial involvement of opioid peptides in SRIH action might be supposed. Alternatively, SRIH and naloxone-sensitive opiates might produce this inhibiting effect on GH rise in response to cigarette smoking through independent pathways.
- 1 March 2011
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 43 (05) , 361-363
Somatostatin Reduces Neuropeptide Y Rise Induced by Physical Exercise
The effect of an i. v. infusion of somatostatin (SRIH) 4.1 μg/min×90 min on the basal secretion of NPY and on the NPY response to physical exercise was studied in normal men. Basal NPY secretion was not modified by SRIH infusion, whereas the NPY response to physical exercise was significantly lower in the presence of SRIH. These data suggest the involvement of a somatostatinergic mechanism in the regulation of NPY response to physical exercise.
- 1 March 2011
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 43 (05) , 361-363
Somatostatin Reduces Neuropeptide Y Rise Induced by Physical Exercise
The effect of an i. v. infusion of somatostatin (SRIH) 4.1 μg/min×90 min on the basal secretion of NPY and on the NPY response to physical exercise was studied in normal men. Basal NPY secretion was not modified by SRIH infusion, whereas the NPY response to physical exercise was significantly lower in the presence of SRIH. These data suggest the involvement of a somatostatinergic mechanism in the regulation of NPY response to physical exercise.
- 1 January 2011
- Published by Elsevier in Regulatory Peptides
- Vol. 166 (1-3) , 1-2
Stimulatory effect of naloxone on plasma cortisol in human: Possible direct stimulatory action at the adrenal cortex
- 1 January 2011
- Published by Elsevier in Regulatory Peptides
- Vol. 166 (1-3) , 1-2
Stimulatory effect of naloxone on plasma cortisol in human: Possible direct stimulatory action at the adrenal cortex
- Open Access
- 30 December 2010
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 71 (6) , 951-955
Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercise in man
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Alprazolam (ALP), a benzodiazepine activating GABAergic receptors, is involved in ACTH secretion. WHAT THIS STUDY ADDS • This study demonstrates a partial opioid influence in the inhibitory effect of ALP on the release of ACTH/cortisol during physical exercise.AIMS To establish the possible involvement of alprazolam (ALP) and/or opiates in the mechanism underlying the ACTH/cortisol response to physical exercise.METHODS Tests were carried out under basal conditions (exercise control test), exercise plus ALP (50 µg at time −90 min), naloxone (10 mg at time 0) or ALP plus naloxone. Plasma ACTH and serum cortisol concentrations were evaluated in blood samples taken before, during and after the bicycle ergometer tests.RESULTS ACTH and cortisol concentrations rose significantly after physical exercise. Maximum peak at time 15 min (P ≤ 0.01 vs. baseline) for ACTH and at time 30 min (P ≤ 0.01 vs. baseline) for cortisol. In the presence of naloxone, the ACTH and cortisol responses were significantly increased (maximum peak at time 20 min, P ≤ 0.02 vs. control test for ACTH, and at time 30 min (P ≤ 0.01 vs. baseline) for cortisol) whereas they were abolished by ALP. When ALP and naloxone were given together, the inhibitory effect of ALP was partial.CONCLUSIONS These data demonstrate an inhibitory effect of ALP in the regulation of the ACTH/cortisol response to physical exercise in man and suggest that GABAergic receptor activating benzodiazepines and opioids interact in the neuroendocrine secretion of ACTH/cortisol.
- 30 December 2010
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 71 (6) , 951-955
Open AccessNaloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercise in man
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Alprazolam (ALP), a benzodiazepine activating GABAergic receptors, is involved in ACTH secretion. WHAT THIS STUDY ADDS • This study demonstrates a partial opioid influence in the inhibitory effect of ALP on the release of ACTH/cortisol during physical exercise.AIMS To establish the possible involvement of alprazolam (ALP) and/or opiates in the mechanism underlying the ACTH/cortisol response to physical exercise.METHODS Tests were carried out under basal conditions (exercise control test), exercise plus ALP (50 µg at time −90 min), naloxone (10 mg at time 0) or ALP plus naloxone. Plasma ACTH and serum cortisol concentrations were evaluated in blood samples taken before, during and after the bicycle ergometer tests.RESULTS ACTH and cortisol concentrations rose significantly after physical exercise. Maximum peak at time 15 min (P ≤ 0.01 vs. baseline) for ACTH and at time 30 min (P ≤ 0.01 vs. baseline) for cortisol. In the presence of naloxone, the ACTH and cortisol responses were significantly increased (maximum peak at time 20 min, P ≤ 0.02 vs. control test for ACTH, and at time 30 min (P ≤ 0.01 vs. baseline) for cortisol) whereas they were abolished by ALP. When ALP and naloxone were given together, the inhibitory effect of ALP was partial.CONCLUSIONS These data demonstrate an inhibitory effect of ALP in the regulation of the ACTH/cortisol response to physical exercise in man and suggest that GABAergic receptor activating benzodiazepines and opioids interact in the neuroendocrine secretion of ACTH/cortisol.